Table 1 Characteristics and symptoms of 108 patients with laboratory-confirmed Nephropathia epidemica
From: No gender-related differences in the severity of nephropathia epidemica, Germany
Male | Female | P value | |
|---|---|---|---|
n = 82 | n = 26 | ||
Median age in years (range) | 42 (18–81) | 40.5 (19–68) | 0.4083 |
Median admission after onset of symptoms in days (range) | 6 (0–17) | 5 (3–17) | 0.9607 |
Median duration of hospitalization in days (range) | 7 (0–29) | 7 (1–12) | 0.5269 |
Fever | 70 (85.37%) | 22 (84.62%) | 1.0000 |
Headache | 60 (73.17%) | 20 (76.92%) | 0.8014 |
Nausea | 51 (62.20%) | 21 (80.77%) | 0.0975 |
Side/back pain | 49 (59.76%) | 21 (80.77%) | 0.0611 |
Abdominal pain | 46 (56.10%) | 14 (53.85%) | 1.0000 |
Night sweat | 25 (30.49%) | 4 (15.38%) | 0.2032 |
Diarrhea | 25 (30.49%) | 8 (30.77%) | 1.0000 |
Ophthalmological symptoms | 21 (25.61%) | 10 (38.46%) | 0.2218 |
Myalgia | 20 (24.39%) | 15 (57.69%) | 0.0033 |
Weight loss | 18 (21.95%) | 4 (15.38%) | 0.5833 |
Cough | 15 (18.29%) | 4 (15.38%) | 1.0000 |
Edema | 14 (17.07%) | 10 (38.46%) | 0.0308 |
Dyspnea | 7 (8.54%) | 6 (23.08%) | 0.0777 |